Novel Antimicrobial Agents
A section of Antibiotics (ISSN 2079-6382).
Section Information
Welcome to the Novel Antimicrobial Agents section. This section intends to cover and publish all aspects related to new antimicrobials. This section includes, but is not limited to, new antimicrobials, its modifications, new sources of antimicrobials, antimicrobial detection methods and alternative uses of antimicrobials, such as preservatives.
New uses or applications of common antimicrobials are welcome, as well as biological fight as the use of fagos or probiotic bacteria to control pathogenic bacterial populations everywhere, or even the use of new genomic tools to fight against pathogenic bacteria, including new mechanisms of antimicrobial action or mechanisms with effect against virulence factors of bacteria, as is the biofilm formation control.
Moreover, it welcomes reports on synergistic treatments which can increase the power of classical antimicrobials or enlarge the range of microorganisms covered. Likewise, the bacterial resistance development and resistance determinants to new compounds or the bacteria behavior regarding antimicrobial strategies are also in the scope of the section as well as the fight against multidrug resistant bacteria.
Finally, in the COVID-19 era, great attention is now being dedicated to the fight against viruses, particularly COVID-19, with new compounds or strategies to fight against the survival of these agents, or as therapeutic alternatives. This wide scope can attract a lot of new and exciting ideas for a better control of microorganisms in a densely populated world.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Organic Synthesis of Drug-Like Antimicrobial Compounds (Deadline: 15 May 2024)
- Honey: A Sweet Solution to the Growing Problem of Antimicrobial Resistance, 2nd Volume (Deadline: 31 May 2024)
- Design and Discovery of New Antibacterial Agents: Past, Evolution, and Perspectives (Deadline: 1 June 2024)
- Antimicrobial Drug Discovery: New Theories and New Therapies (Deadline: 30 June 2024)
- Natural Compounds as Antimicrobial Agents, 2nd Volume (Deadline: 15 July 2024)
- Synthesis of Novel Antimicrobial Agents, 2nd Volume (Deadline: 31 July 2024)
- Nanoparticles-Based Antimicrobials, 2nd Edition (Deadline: 15 August 2024)
- New Approaches in Antimicrobial Drug Discovery and Design (Deadline: 31 August 2024)
- Recent Advances in Antimicrobial Drug Discovery, 2nd Volume (Deadline: 31 August 2024)
- Design and Synthesis of Novel Antibiotics (Deadline: 31 August 2024)
- Antimicrobial Resistance and Antimicrobial Activity of Natural Products and Derivatives (Deadline: 31 August 2024)
- Innovative and Nonconventional Antimicrobial Strategies Against Multi-Resistant Bacteria (Deadline: 15 September 2024)
- Editorial Board Members’ Collection Series: New Strategies to Overcome Antibiotic Resistance (Deadline: 20 September 2024)
- What’s New: Natural and Synthetic Antibacterials and/or Agents with Multiple Activities? 3rd Volume (Deadline: 31 October 2024)
- Synthetic and Natural Products-Based Antimicrobial and Antiparasitic Agents (Deadline: 30 November 2024)
- Multitalented Synthetic Antimicrobial Compounds: From Design to Effect (Deadline: 30 November 2024)
- Small Molecules in the Search of Novel Antimicrobials and Antifungals (Deadline: 31 December 2024)
- Advancing the Discovery and Development of New Antibiotics through Drug Repurposing (Deadline: 31 December 2024)
- Discovery and Design of New Antimicrobial Agents (Deadline: 31 December 2024)
- Next Generation Antibiotics: Discoveries, Promises and Challenges (Deadline: 31 December 2024)
- Innovations in Antibacterial Agents: Combating Resistance, Improving Efficacy and Exploring New Mechanisms (Deadline: 30 April 2025)
